{"id":7236,"date":"2025-07-31T12:27:37","date_gmt":"2025-07-31T10:27:37","guid":{"rendered":"https:\/\/semmelweis.hu\/tmk\/?p=7236"},"modified":"2025-11-20T13:44:18","modified_gmt":"2025-11-20T12:44:18","slug":"kinga-budai","status":"publish","type":"post","link":"https:\/\/semmelweis.hu\/tmk\/en\/2025\/07\/31\/kinga-budai\/","title":{"rendered":"Kinga Budai"},"content":{"rendered":"

\"\"Semmelweis University, University Pharmacy, Institute of Pharmaceutical Organisation<\/h4>\n
\n
TOPIC<\/strong><\/div>\n

Pediatrics – infectology and antimicrobial therapy in critical illness.<\/span><\/p>\n<\/div>\n

\n
VISION<\/strong><\/div>\n

Improve the effectiveness of antimicrobial therapy and extend life expectancy in critically ill children.<\/span><\/p>\n<\/div>\n

\n
MISSION<\/strong><\/div>\n

Optimize antibiotic dosing based on serum drug levels and up–to–date evidence in critically ill children.<\/span><\/p>\n<\/div>\n

\n
PROJECT TITLE 1<\/strong><\/div>\n

Extended infusion of β–lactams reduces mortality and enhances microbiological eradication in paediatric patients: systematic review and meta–analysis.<\/span><\/p>\n<\/div>\n

\n
PROJECT TITLE 2<\/strong><\/div>\n

Comparison of efficacy and plasma concentrations of extended versus intermittent infusion of β–lactams in critically ill paediatric patients: randomized clinical trial protocol.<\/span><\/p>\n<\/div>\n

\n
PROJECT TITLE 3<\/strong><\/div>\n

Monitoring antimicrobial plasma concentrations at different points of the extracorporeal blood circuit during CKRT therapy.<\/span><\/p>\n<\/div>\n

\r\n
\r\n
\r\n
\r\n